Second-generation androgen receptor inhibitors in therapy of non-metastatic castration resistant prostate cancer: role of safety profile and effect on quality of life. Вопр. онкол. [Internet]. 2022 May 6 [cited 2026 Oct. 14];67(2):217-26. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1202